Amdocs (DOX) Cash & Equivalents (2009 - 2026)

Amdocs (DOX) has reported Cash & Equivalents for 18 consecutive years, with $206.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 22.77% year-over-year to $206.5 million in Q2 2026; TTM through Jun 2026 was $206.5 million, a 22.77% decrease from a year earlier, with the FY2025 full-year figure at $325.0 million, down 6.09% from the prior year.
• Cash & Equivalents was $206.5 million for Q2 2026 at Amdocs, down from $214.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $623.4 million in Q1 2023 and troughed at $206.5 million in Q2 2026.
• A 5-year average of $390.5 million and a median of $344.5 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 44.99% in 2024 and increased 15.92% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $492.2 million in 2022, then decreased by 22.21% to $382.9 million in 2023, then plunged by 44.15% to $213.8 million in 2024, then advanced by 15.92% to $247.9 million in 2025, then dropped by 16.71% to $206.5 million in 2026.
• The last three Cash & Equivalents figures came in at $206.5 million (Q2 2026), $214.5 million (Q1 2026), and $247.9 million (Q4 2025), per Business Quant data.